For more information or confidential assistance
Call 800-306-3180

Research Reveals the High Risks of Pradaxa

New research into the popular blood thinners dabigatran (brand name Pradaxa) and warfarin (brand name Coumadin) indicate that the risks associated with dabigatran – Pradaxa internal bleeding, hemorrhaging, and even death from Pradaxa – are greater than those linked to warfarin. This information will likely... Read More

Federal Court Considers Motion for Pradaxa MDL

In response to the ballooning number of plaintiffs choosing to file a Pradaxa lawsuit, a motion has been filed with the U.S. Judicial Panel on Multidistrict Litigation seeking to consolidate lawsuits against Pradaxa manufacturer Boehringer Ingelheim that share common issues of fact. The motion seeks... Read More

Pradaxa Deaths Increase Lawsuits

Pradaxa is a blood thinning medication that was introduced relatively recently as an alternative to older blood thinning drugs. However, a number of patients have experienced complications and side effects as a result of their use of the drug, and a number of them have... Read More

Pradaxa Could Be More Dangerous Than Alternative

Pradaxa was introduced as an atrial fibrillation treatment in 2010 by the Food and Drug Administration, who approved the drug as an alternative to the previously used warfarin, known by its brand name Coumadin most commonly. Pradaxa is manufactured by drug maker Boehringer Ingelheim Pharmaceuticals.... Read More